Preserving muscle is an alluring goal for drugmakers that missed the first generation of obesity treatments and are seeking a foothold in the fast-growing and lucrative field

Biotech company Regeneron said its rheumatoid arthritis drug Kevzara failed to meet the main goals of a US study testing it in the most critically ill Covid-19 patients

Biotech company Regeneron, which has a major industrial operations centre in Limerick, has begun human trials of a new antibody cocktail for Covid-19.

Biotech company Regeneron is to increase the number of medicines manufactured at its Limerick facility in order to ramp up production of their COVID-19 drug treatment in the US.